SlideShare a Scribd company logo
1 of 21
Critical Success Factors   ,[object Object]
Critical Success Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Business Plan ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Funding ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Personal Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
People ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Product Development ,[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Approval ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Product Champions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Need for Reimbursement ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reimbursement in Business Plan ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reimbursement Cycle ,[object Object],[object Object],[object Object],Payment For Medical  Device CPT for  Doctor’s  Services DRG For Hospital
What Are DRG’s/CPT’s? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Financial Performance ,[object Object],[object Object],[object Object],[object Object],[object Object]
“ Free” Stuff ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Business Protection ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Sales, Marketing and Clinical ,[object Object],[object Object],[object Object],[object Object]
Stark Laws ,[object Object],[object Object],Hospital Doctor Device  Company
Stark Law’s Basic Prohibitions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Ten Perceptions That Can Kill A Company  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Success

More Related Content

What's hot

Top 10 regulatory affairs specialist interview questions and answers
Top 10 regulatory affairs specialist interview questions and answersTop 10 regulatory affairs specialist interview questions and answers
Top 10 regulatory affairs specialist interview questions and answers
romeo23113
 
Msl activities-and-performance-measurement-cutting-edge-information-ph178-bro...
Msl activities-and-performance-measurement-cutting-edge-information-ph178-bro...Msl activities-and-performance-measurement-cutting-edge-information-ph178-bro...
Msl activities-and-performance-measurement-cutting-edge-information-ph178-bro...
Manny Garcia MD
 

What's hot (20)

Clamoxyl ppt 5.3.18
Clamoxyl ppt 5.3.18Clamoxyl ppt 5.3.18
Clamoxyl ppt 5.3.18
 
Esomeprazole plan
Esomeprazole planEsomeprazole plan
Esomeprazole plan
 
Strategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devicesStrategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devices
 
New launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brandNew launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brand
 
Secondary Metabolites from Mimosa Pudica: Isolation, Purification and NMR Cha...
Secondary Metabolites from Mimosa Pudica: Isolation, Purification and NMR Cha...Secondary Metabolites from Mimosa Pudica: Isolation, Purification and NMR Cha...
Secondary Metabolites from Mimosa Pudica: Isolation, Purification and NMR Cha...
 
Pharmaceutical marketing course
Pharmaceutical marketing coursePharmaceutical marketing course
Pharmaceutical marketing course
 
Pharmaceutical Marketing Presentation
Pharmaceutical Marketing PresentationPharmaceutical Marketing Presentation
Pharmaceutical Marketing Presentation
 
Things to do before making doctor calls
Things to do before making doctor callsThings to do before making doctor calls
Things to do before making doctor calls
 
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medix
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio MedixHow Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medix
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medix
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
 
Pharmaceutical Marketing Strategy
Pharmaceutical Marketing StrategyPharmaceutical Marketing Strategy
Pharmaceutical Marketing Strategy
 
Lifecycle Management in the Pharmaceutical Industry
Lifecycle Management in the Pharmaceutical IndustryLifecycle Management in the Pharmaceutical Industry
Lifecycle Management in the Pharmaceutical Industry
 
Top 10 regulatory affairs specialist interview questions and answers
Top 10 regulatory affairs specialist interview questions and answersTop 10 regulatory affairs specialist interview questions and answers
Top 10 regulatory affairs specialist interview questions and answers
 
Introduction to Medico-Marketing
Introduction to Medico-MarketingIntroduction to Medico-Marketing
Introduction to Medico-Marketing
 
New Directions in Drug Approval in Canada
New Directions in Drug Approval in CanadaNew Directions in Drug Approval in Canada
New Directions in Drug Approval in Canada
 
Pharma marketing
Pharma marketingPharma marketing
Pharma marketing
 
Medical sales skills needed for success in the new healthcare environment
Medical sales skills needed for success in the new healthcare environmentMedical sales skills needed for success in the new healthcare environment
Medical sales skills needed for success in the new healthcare environment
 
Msl activities-and-performance-measurement-cutting-edge-information-ph178-bro...
Msl activities-and-performance-measurement-cutting-edge-information-ph178-bro...Msl activities-and-performance-measurement-cutting-edge-information-ph178-bro...
Msl activities-and-performance-measurement-cutting-edge-information-ph178-bro...
 
New Launch Strategy & Product Cycle
New Launch Strategy & Product CycleNew Launch Strategy & Product Cycle
New Launch Strategy & Product Cycle
 
Marketing of a pharma (Basic)
Marketing of a pharma (Basic)Marketing of a pharma (Basic)
Marketing of a pharma (Basic)
 

Similar to Critical Success Factors for a Medical Device Company

Speeding Towards Commercialization Gra 121808 Final
Speeding Towards Commercialization   Gra 121808 FinalSpeeding Towards Commercialization   Gra 121808 Final
Speeding Towards Commercialization Gra 121808 Final
securbme
 
Growththroughacquisition
GrowththroughacquisitionGrowththroughacquisition
Growththroughacquisition
woinman
 
biotech bulletin-2015-spring
biotech bulletin-2015-springbiotech bulletin-2015-spring
biotech bulletin-2015-spring
Brian Filippini
 
Biotech Bulletin - Summer 2015
Biotech Bulletin - Summer 2015Biotech Bulletin - Summer 2015
Biotech Bulletin - Summer 2015
Regina M Maxwell
 
The Aequitas Group Capabilities Overview Q409
The Aequitas Group Capabilities Overview Q409The Aequitas Group Capabilities Overview Q409
The Aequitas Group Capabilities Overview Q409
bmeunier9
 
Presentation_ Strategic Planning Wellpoint.ppt
Presentation_   Strategic Planning Wellpoint.pptPresentation_   Strategic Planning Wellpoint.ppt
Presentation_ Strategic Planning Wellpoint.ppt
Johnny Schaefer
 

Similar to Critical Success Factors for a Medical Device Company (20)

Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
 
Life Science Codes of Conduct
Life Science Codes of ConductLife Science Codes of Conduct
Life Science Codes of Conduct
 
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2016
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2016Mercer Capital's Value Focus: Medical Technology | Mid-Year 2016
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2016
 
Maetrics: The ROI of Good Quality & Compliance
Maetrics: The ROI of Good Quality & ComplianceMaetrics: The ROI of Good Quality & Compliance
Maetrics: The ROI of Good Quality & Compliance
 
Converge Advisory Group
Converge Advisory GroupConverge Advisory Group
Converge Advisory Group
 
Regulatory Affairs
Regulatory AffairsRegulatory Affairs
Regulatory Affairs
 
Speeding Towards Commercialization Gra 121808 Final
Speeding Towards Commercialization   Gra 121808 FinalSpeeding Towards Commercialization   Gra 121808 Final
Speeding Towards Commercialization Gra 121808 Final
 
179882
179882179882
179882
 
Growththroughacquisition
GrowththroughacquisitionGrowththroughacquisition
Growththroughacquisition
 
SPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
SPI Insight: Taking the Pulse of Big Changes in Healthcare SalesSPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
SPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
 
biotech bulletin-2015-spring
biotech bulletin-2015-springbiotech bulletin-2015-spring
biotech bulletin-2015-spring
 
Biotech Bulletin 2Q2015
Biotech Bulletin 2Q2015Biotech Bulletin 2Q2015
Biotech Bulletin 2Q2015
 
Massachusetts Marketing Code of Conduct
Massachusetts Marketing Code of Conduct Massachusetts Marketing Code of Conduct
Massachusetts Marketing Code of Conduct
 
Elevating the Health of Healthcare: A Four Step Guide
Elevating the Health of Healthcare: A Four Step GuideElevating the Health of Healthcare: A Four Step Guide
Elevating the Health of Healthcare: A Four Step Guide
 
CIMIT Innovation Grand Rounds
CIMIT Innovation Grand RoundsCIMIT Innovation Grand Rounds
CIMIT Innovation Grand Rounds
 
Clinician Scientists and SR&ED
Clinician Scientists and SR&EDClinician Scientists and SR&ED
Clinician Scientists and SR&ED
 
Biotech Bulletin - Summer 2015
Biotech Bulletin - Summer 2015Biotech Bulletin - Summer 2015
Biotech Bulletin - Summer 2015
 
Ferrari chapter
Ferrari chapterFerrari chapter
Ferrari chapter
 
The Aequitas Group Capabilities Overview Q409
The Aequitas Group Capabilities Overview Q409The Aequitas Group Capabilities Overview Q409
The Aequitas Group Capabilities Overview Q409
 
Presentation_ Strategic Planning Wellpoint.ppt
Presentation_   Strategic Planning Wellpoint.pptPresentation_   Strategic Planning Wellpoint.ppt
Presentation_ Strategic Planning Wellpoint.ppt
 

More from Dickson Consulting

More from Dickson Consulting (20)

Letter of comment to DOC Titanium Sponge Working Group
Letter of comment to DOC Titanium Sponge Working GroupLetter of comment to DOC Titanium Sponge Working Group
Letter of comment to DOC Titanium Sponge Working Group
 
Dickson's Poems
Dickson's PoemsDickson's Poems
Dickson's Poems
 
Now is the time to evaluate solar and wind generated power
Now is the time to evaluate solar and wind generated powerNow is the time to evaluate solar and wind generated power
Now is the time to evaluate solar and wind generated power
 
Titanium Sponge
Titanium SpongeTitanium Sponge
Titanium Sponge
 
SPAC Attack: SEC 12/22/2020 Disclosure Guidelines
SPAC Attack: SEC 12/22/2020 Disclosure GuidelinesSPAC Attack: SEC 12/22/2020 Disclosure Guidelines
SPAC Attack: SEC 12/22/2020 Disclosure Guidelines
 
Letter to SEC on Finders
Letter to SEC on FindersLetter to SEC on Finders
Letter to SEC on Finders
 
CMS Proposal--Valley of Death
CMS Proposal--Valley of DeathCMS Proposal--Valley of Death
CMS Proposal--Valley of Death
 
Fitting the Pieces Together
Fitting the Pieces TogetherFitting the Pieces Together
Fitting the Pieces Together
 
Role of the Chief Financial Officer
Role of the Chief Financial OfficerRole of the Chief Financial Officer
Role of the Chief Financial Officer
 
Creating a M&A Advisory Board
Creating a M&A Advisory BoardCreating a M&A Advisory Board
Creating a M&A Advisory Board
 
Now is the Time for CEO's, COO's and CFO's to Evaluate the Use of Solar Panels
Now is the  Time for CEO's, COO's and CFO's to Evaluate the Use of Solar PanelsNow is the  Time for CEO's, COO's and CFO's to Evaluate the Use of Solar Panels
Now is the Time for CEO's, COO's and CFO's to Evaluate the Use of Solar Panels
 
Professional Services to Support VC and PE Activity
Professional Services to Support VC and PE ActivityProfessional Services to Support VC and PE Activity
Professional Services to Support VC and PE Activity
 
Audit Committee:Financial Leadership From The Top
Audit Committee:Financial Leadership From The TopAudit Committee:Financial Leadership From The Top
Audit Committee:Financial Leadership From The Top
 
Professional Services to Support M&A Activity
Professional Services to Support M&A ActivityProfessional Services to Support M&A Activity
Professional Services to Support M&A Activity
 
Entrepreneur at the Controls
Entrepreneur at the ControlsEntrepreneur at the Controls
Entrepreneur at the Controls
 
401k Education
401k Education401k Education
401k Education
 
Financial Reporting for Entrepreneurs
Financial Reporting for EntrepreneursFinancial Reporting for Entrepreneurs
Financial Reporting for Entrepreneurs
 
Financial Tips for Survival
Financial Tips for SurvivalFinancial Tips for Survival
Financial Tips for Survival
 
Physician Payment Sunshine Act
Physician Payment Sunshine ActPhysician Payment Sunshine Act
Physician Payment Sunshine Act
 
Response to FDA on Off-Label Use
Response to FDA on Off-Label UseResponse to FDA on Off-Label Use
Response to FDA on Off-Label Use
 

Recently uploaded

一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
atedyxc
 
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
atedyxc
 
TriStar Gold- 05-13-2024 corporate presentation
TriStar Gold- 05-13-2024 corporate presentationTriStar Gold- 05-13-2024 corporate presentation
TriStar Gold- 05-13-2024 corporate presentation
Adnet Communications
 
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
Klinik kandungan
 
Abortion pills in Dammam Saudi Arabia | +966572737505 |Get Cytotec
Abortion pills in Dammam Saudi Arabia | +966572737505 |Get CytotecAbortion pills in Dammam Saudi Arabia | +966572737505 |Get Cytotec
Abortion pills in Dammam Saudi Arabia | +966572737505 |Get Cytotec
Abortion pills in Riyadh +966572737505 get cytotec
 

Recently uploaded (20)

Satoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdf
Satoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdfSatoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdf
Satoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdf
 
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
 
amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...
 
Q1 2024 Conference Call Presentation vF.pdf
Q1 2024 Conference Call Presentation vF.pdfQ1 2024 Conference Call Presentation vF.pdf
Q1 2024 Conference Call Presentation vF.pdf
 
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
 
Pitch-deck CopyFinancial and MemberForex.ppsx
Pitch-deck CopyFinancial and MemberForex.ppsxPitch-deck CopyFinancial and MemberForex.ppsx
Pitch-deck CopyFinancial and MemberForex.ppsx
 
asli amil baba bengali black magic kala jadu expert in uk usa canada france c...
asli amil baba bengali black magic kala jadu expert in uk usa canada france c...asli amil baba bengali black magic kala jadu expert in uk usa canada france c...
asli amil baba bengali black magic kala jadu expert in uk usa canada france c...
 
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
 
kala jadu in canada | amil baba pakistan \ black magic expert
kala jadu in canada | amil baba pakistan \ black magic expertkala jadu in canada | amil baba pakistan \ black magic expert
kala jadu in canada | amil baba pakistan \ black magic expert
 
TriStar Gold- 05-13-2024 corporate presentation
TriStar Gold- 05-13-2024 corporate presentationTriStar Gold- 05-13-2024 corporate presentation
TriStar Gold- 05-13-2024 corporate presentation
 
Economic Risk Factor Update: May 2024 [SlideShare]
Economic Risk Factor Update: May 2024 [SlideShare]Economic Risk Factor Update: May 2024 [SlideShare]
Economic Risk Factor Update: May 2024 [SlideShare]
 
Retail sector trends for 2024 | European Business Review
Retail sector trends for 2024  | European Business ReviewRetail sector trends for 2024  | European Business Review
Retail sector trends for 2024 | European Business Review
 
Amil baba australia kala jadu in uk black magic in usa
Amil baba australia kala jadu in uk black magic in usaAmil baba australia kala jadu in uk black magic in usa
Amil baba australia kala jadu in uk black magic in usa
 
Shrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdfShrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdf
 
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
 
Amil baba powerful kala jadu in islamabad rawalpindi - Amil baba in lahore Am...
Amil baba powerful kala jadu in islamabad rawalpindi - Amil baba in lahore Am...Amil baba powerful kala jadu in islamabad rawalpindi - Amil baba in lahore Am...
Amil baba powerful kala jadu in islamabad rawalpindi - Amil baba in lahore Am...
 
amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...
 
Abortion pills in Dammam Saudi Arabia | +966572737505 |Get Cytotec
Abortion pills in Dammam Saudi Arabia | +966572737505 |Get CytotecAbortion pills in Dammam Saudi Arabia | +966572737505 |Get Cytotec
Abortion pills in Dammam Saudi Arabia | +966572737505 |Get Cytotec
 
L1 2024 Prequisite QM persion milad1371.pdf
L1 2024 Prequisite QM persion milad1371.pdfL1 2024 Prequisite QM persion milad1371.pdf
L1 2024 Prequisite QM persion milad1371.pdf
 
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
 

Critical Success Factors for a Medical Device Company

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.